Download PDF
Homœopathic Links 2023; 36(03): 237-242
DOI: 10.1055/s-0040-1721059
Case Report

Homoeopathy in Psoriasis Vulgaris with Special Emphasis on Modified Naranjo Criteria for Homeopathy: An Evidence-Based Case Report

Rajib Purkait 
1   Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt. of India, Siliguri, West Bengal, India
,
Abhiram Banerjee 
1   Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt. of India, Siliguri, West Bengal, India
,
Gurudev Choubey 
1   Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt. of India, Siliguri, West Bengal, India
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Background Psoriasis is a chronic multisystem inflammatory disease with predominantly skin and joint involvement. Ample evidences suggest that psoriasis patients improve under homoeopathic treatment. The main objective of this documentation is to find out whether such improvement can be attributable to the homoeopathic treatment.

Method A case of psoriasis vulgaris with the complaint of dry, scaly itching eruption on the extensor surface of both legs is presented here. Outcome-related to impact on daily living (ORIDL) was used to evaluate the patient-reported outcome related to his daily living, disease severity in the involved area was assessed by PASI (Psoriasis Area and Severity Index) scale and PDI (Psoriasis Disability Index) scale was used to assess the disease-specific quality of life. Photographs were taken as objective evidence after obtaining consent from the patient. The Modified Naranjo Criteria for Homeopathy (MONARCH) was used to find out the possible causal attribution of the treatment provided.

Result The ORIDL score of (+4) showed the major improvement from patient and physician's perspective. PASI score reduced from ‘11.2 to 0’ (documented in photographs) within a plausible timeframe. The duration of remission of the skin lesion continued for six months. Each domain of PDI score reduced (from ‘25 to 3′) imparting improved quality of life. The high total score (+9 in ‘−6 to 13’ scale) of MONARCH suggested the likelihood of improvement was attributable to the homoeopathic intervention. This case has evidently shown its marked improvement with validated outcome measures.

Keywords

psoriasis vulgaris - homoeopathy - Staphysagria - MONARCH - case report - HOM-CASE

Funding

None.


Informed Consent

Informed consent has been obtained from the patient.




Publication History

Article published online:
19 July 2023

© 2023. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician 2017; 63 (04) 278-285
    PubMedGoogle Scholar
  • 2 Griffiths CEM, Christophers E, Barker JNWN. et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 2007; 156 (02) 258-262
    CrossrefPubMedGoogle Scholar
  • 3 Gibbs S. Skin disease and socioeconomic conditions in rural Africa: Tanzania. Int J Dermatol 1996; 35 (09) 633-639
    CrossrefPubMedGoogle Scholar
  • 4 Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol 2013; 168 (06) 1303-1310
    CrossrefPubMedGoogle Scholar
  • 5 Thappa DM, Munisamy M. Research on psoriasis in India: where do we stand?. Indian J Med Res 2017; 146 (02) 147-149
    CrossrefPubMedGoogle Scholar
  • 6 Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol 2010; 76 (06) 595-601
    CrossrefPubMedGoogle Scholar
  • 7 Fujii R, Mould J, Tang B. et al. Burden of disease in patients with diagnosed psoriasis in Brazil: results from 2011 National Health and Wellness Survey (NHWS). Value Health 2012; 15 (04) A107
    CrossrefPubMedGoogle Scholar
  • 8 Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9 (02) 136-139
    CrossrefPubMedGoogle Scholar
  • 9 Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005; 6 (06) 383-392
    CrossrefPubMedGoogle Scholar
  • 10 Owczarek K, Jaworski M. Quality of life and severity of skin changes in the dynamics of psoriasis. Postepy Dermatol Alergol 2016; 33 (02) 102-108
    CrossrefPubMedGoogle Scholar
  • 11 Langley RG, Gupta AK, Cherman AM, Inniss KA. Biologic therapeutics in the treatment of psoriasis. Part 1: review. Review J Cutan Med Surg 2007; 11 (03) 99-122
    CrossrefPubMedGoogle Scholar
  • 12 Reich K, Mrowietz U. Treatment goals in psoriasis. J Dtsch Dermatol Ges 2007; 5 (07) 566-574
    CrossrefPubMedGoogle Scholar
  • 13 Katugampola RP, Lewis VJ, Finlay AY. The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis. Br J Dermatol 2007; 156 (05) 945-950
    CrossrefPubMedGoogle Scholar
  • 14 Witt CM, Lüdtke R, Willich SN. Homeopathic treatment of patients with psoriasis–a prospective observational study with 2 years follow-up. J Eur Acad Dermatol Venereol 2009; 23 (05) 538-543
    CrossrefPubMedGoogle Scholar
  • 15 World Health Organization (WHO). Global Report on Psoriasis. Switzerland: World Health Organization; 2020
    Google Scholar
  • 16 Khanna N. Illustrated Synopsis of Dermatology & Sexually Transmitted Diseases. 5th edition. Haryana: Elsevier India; 2017: 44-47
    Google Scholar
  • 17 Hahnemann CFS. Organon of Medicine. Dudgeon RE and Boericke W (Translators). 5th & 6th edition. New Delhi: IBPP; 2006
    Google Scholar
  • 18 Kent JT. Repertory of the Homoeopathic Materia Medica. 6th edition. New Delhi: B Jain Publishers; 2016
    Google Scholar
  • 19 Boericke W. Boericke's New Manual of Homoeopathic Materia Medica with Repertory. 9th edition. New Delhi: B Jain Publishers; 2013
    Google Scholar
  • 20 Phatak SR. A Concise Repertory of Homoeopathic Medicines. 4th edition. New Delhi: B Jain Publishers; 2014
    Google Scholar
  • 21 Murphy R. Homoeopathic Medical Repertory. 3rd edition. New Delhi: B Jain Publishers Pvt. Ltd.; 2014
    Google Scholar
  • 22 Sharma B. Homeopathy medicine for treatment of psoriasis. Int J Homoeopath Sci 2018; 2 (04) 17-19
    CrossrefPubMedGoogle Scholar
  • 23 Nwabudike LC. Psoriasis and homeopathy. Proc Rom Acad. Ser B 2011; 3: 237-242
    PubMedGoogle Scholar
  • 24 Rajendran ES. Psoriasis and Natrum muriaticum. Allg Homöopathische Zeitung 2005; 250 (02) 83
    PubMedGoogle Scholar
  • 25 Rahman S, Dey JK. A case report of plantar psoriasis treated with homoeopathy. Homœopathic Links 2018; 31 (04) 248-253
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 van Haselen RA. Homeopathic clinical case reports: development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med 2016; 25: 78-85
    CrossrefPubMedGoogle Scholar
  • 27 Kent JT. Lectures on Homeopathic Philosophy. Repr 4th edition. New Delhi: B Jain Publishers; 1997
    Google Scholar
  • 28 Reilly D, Mercer SW, Bikker AP, Harrison T. Outcome related to impact on daily living: preliminary validation of the ORIDL instrument. BMC Health Serv Res 2007; 7 (01) 139
    CrossrefPubMedGoogle Scholar
  • 29 Langley RG, Ellis CN. Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment. J Am Acad Dermatol 2004; 51 (04) 563-569
    CrossrefPubMedGoogle Scholar
  • 30 Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990; 123 (06) 751-756
    CrossrefPubMedGoogle Scholar
  • 31 Stub T, Kristoffersen AE, Alræk T, Musial F, Steinsbekk A. Risk in homeopathy: classification of adverse events and homeopathic aggravations–a cross sectional study among Norwegian homeopath patients. Complement Ther Med 2015; 23 (04) 535-543
    CrossrefPubMedGoogle Scholar
  • 32 Stub T, Salamonsen A, Alraek T. Is it possible to distinguish homeopathic aggravation from adverse effects? A qualitative study. Forsch Komplement Med 2012; 19 (01) 13-19
    CrossrefPubMedGoogle Scholar
  • 33 Srinivasan SR, Ramya G. Adverse drug reaction-causality assessment. Int J Res Pharm Chem 2011; 1 (03) 606-612
    PubMedGoogle Scholar
  • 34 Naranjo CA, Busto U, Sellers EM. et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30 (02) 239-245
    CrossrefPubMedGoogle Scholar
  • 35 Lamba CD, Gupta VK, van Haselen R. et al. Evaluation of the modified Naranjo criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy 2020; 109 (04) 191-197
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Bhadoriya Y. Homeopathic approaches for the management of psoriasis: a review. Himal J Heal Sci 2020; 5 (02) 5-8
    PubMedGoogle Scholar
  • 37 Velappan R, Venu S, Ramasamy S, Chellappan L. Current scenario in clinical trends of psoriasis in tertiary care hospital. Int J Res Dermatol 2019; 5 (03) 452
    CrossrefPubMedGoogle Scholar
  • 38 Nwabudike LC. Palmar and plantar psoriasis and homeopathy-case reports. Our Dermatol Online 2017; 8 (01) 66-69
    CrossrefPubMedGoogle Scholar
  • 39 Wu Q, Xu Z, Dan Y-L. et al. Seasonality and global public interest in psoriasis: an infodemiology study. Postgrad Med J 2020; 96 (1133): 139-143
    CrossrefPubMedGoogle Scholar
  • 40 Linden A. Assessing regression to the mean effects in health care initiatives. BMC Med Res Methodol 2013; 13 (01) 119
    CrossrefPubMedGoogle Scholar